• Publications
  • Influence
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
F. A. Peccatori1, H. A. Azim Jr2, R. Orecchia3, H. J. Hoekstra4, N. Pavlidis5, V. Kesic6 & G. Pentheroudakis5, on behalf of the ESMO Guidelines Working Group* Fertility and Procreation Unit, DivisionExpand
  • 416
  • 26
Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy
Background—In patients with aggressive malignancies who are undergoing high-dose chemotherapy, even minimal elevation of troponin I (TnI) is associated with late left ventricular dysfunction. TheExpand
  • 670
  • 21
Breast cancer in pregnancy: recommendations of an international consensus meeting.
PURPOSE To provide guidance for clinicians about the diagnosis, staging and treatment of breast cancer occurring during an otherwise uncomplicated pregnancy. METHODS An international expert PanelExpand
  • 194
  • 14
  • PDF
Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.
PURPOSE We questioned the impact of pregnancy on disease-free survival (DFS) in women with history of breast cancer (BC) according to estrogen receptor (ER) status. PATIENTS AND METHODS AExpand
  • 187
  • 11
  • PDF
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).
The 3rd International Consensus Conference for Breast Cancer in Young Women (BCY3) took place in November 2016, in Lugano, Switzerland organized by the European School of Oncology (ESO) and theExpand
  • 135
  • 10
Cancer and fertility preservation: international recommendations from an expert meeting
In the last years, thanks to the improvement in the prognosis of cancer patients, a growing attention has been given to the fertility issues. International guidelines on fertility preservation inExpand
  • 313
  • 7
Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.
BACKGROUND Pregnancy-associated breast cancer (PABC) is relatively rare with considerable controversy regarding its prognosis. PATIENTS & METHODS Two of the authors independently performed aExpand
  • 142
  • 5
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized
BACKGROUND The role of temporary ovarian suppression with luteinizing hormone-releasing hormone agonists (LHRHa) in the prevention of chemotherapy-induced premature ovarian failure (POF) is stillExpand
  • 148
  • 5
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer.
EUSOMA (The European Society of Breast Cancer Specialists) is committed to writing recommendations on different topics of breast cancer care which can be easily adopted and used by healthExpand
  • 211
  • 4
  • PDF
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.
Safety of pregnancy in women with history of estrogen receptor (ER)-positive breast cancer remains controversial. In this multicenter case-control study, 333 patients with pregnancy after breastExpand
  • 61
  • 4